Anxiety and depression, attention, and executive functions in hypothyroidism
For patients considering GLP-1 therapy, understanding your baseline cardiovascular risk profile and metabolic biomarkers before starting treatment can clarify realistic expectations and help align therapy goals with your health priorities
Unlike the supplement industry's usual suspects, which tend to promise everything and deliver little, GHK-Cu has built its reputation the hard way: through peer-reviewed research, clinical trials, and reproducible results across multiple applications
Acc Chem Res 43:14081419
During the first few weeks, most participants experience reduced appetite and a pronounced feeling of fullness after small meals, alongside gastrointestinal effects such as nausea, bloating, and diarrhoea